Lung cancer screening among liver transplant recipients
- PMID: 37039568
- DOI: 10.1097/LVT.0000000000000155
Lung cancer screening among liver transplant recipients
Comment on
-
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients.Liver Transpl. 2023 Oct 1;29(10):1100-1108. doi: 10.1097/LVT.0000000000000121. Epub 2023 Mar 20. Liver Transpl. 2023. PMID: 36929835
References
-
- Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2020 Annual Data Report: Liver. Am J Transplant. 2022;22(Suppl 2):204–309.
-
- Rana A, Ackah RL, Webb GJ, Halazun KJ, Vierling JM, Liu H, Wu MF, et al. No gains in long-term survival after liver transplantation over the past three decades. Ann Surg. 2019;269:20–27.
-
- Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000;232:490–500.
-
- Caballeros Lam M, Pujols P, Ezponda Casajús A, Guillén Valderrama F, García Velloso MJ, Wyss A. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients. Liver Transpl. 2023;29:1100–11108.
-
- National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical